Invention Grant
- Patent Title: Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats
-
Application No.: US15762108Application Date: 2016-09-25
-
Publication No.: US10758609B2Publication Date: 2020-09-01
- Inventor: Janet K. Yamamoto
- Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
- Applicant Address: US FL Gainesville
- Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
- Current Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
- Current Assignee Address: US FL Gainesville
- Agency: Saliwanchik, Lloyd & Eisenschenk
- International Application: PCT/US2016/053624 WO 20160925
- International Announcement: WO2017/053918 WO 20170330
- Main IPC: A61K39/21
- IPC: A61K39/21 ; A61K39/12 ; A61K39/00 ; C07K14/005 ; C12N15/00 ; A61P31/14 ; A61P31/18 ; A61K9/00
Abstract:
The subject invention concerns methods and materials for inducing an immune response in an animal or person against an immunodeficiency virus, such as HIV, SIV, or FIV. In one embodiment, a method of the invention comprises administering one or more antigens and/or immunogens to the person or animal wherein the antigen and/or immunogen comprises one or more evolutionarily conserved epitopes of immunodeficiency viruses. In one embodiment, the epitope is one that is conserved between HIV and FIV.
Public/Granted literature
- US20180333481A1 CROSS-REACTIVE T-CELL EPITOPES OF HIV, SIV, AND FIV FOR VACCINES IN HUMANS AND CATS Public/Granted day:2018-11-22
Information query
